Search Results

Cyclo Therapeutics, Inc. today announced that it has closed the previously announced private placement with Rafael Holdings, Inc. (NYSE:RFL) (“Rafael”) for the purchase of 4,000,000 shares of common stock.

Cyclo Therapeutics, Inc. today announced that it has entered into a binding agreement with Rafael Holdings, Inc. (NYSE:RFL) (“Rafael”) under which Rafael has agreed to purchase 4,000,000 shares of common stock of Cyclo Therapeutics.

Cyclo Therapeutics, Inc. today announced that it has closed a private placement of its securities with Rafael Holdings, Inc. (NYSE:RFL) (“Rafael”) for the purchase of 2,514,970 shares of common stock and warrants.

Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with cancer and rare diseases, today announced the appointment of Rafael G. Amado, M.D., to its Board of Directors, effective today.

ACG, a leading supplier of fully integrated manufacturing solutions to the global pharmaceutical and nutraceutical industries, is pleased to announce the appointment of Rafael Costa as Vice President for the Americas region.

Zai Lab Limited announced that following a distinguished career, Harald Reinhart, M.D., President, Head of Global Development, Neuroscience, Autoimmune and Infectious Diseases of Zai Lab, will retire at the end of June, after which he will serve as a senior advisor for the Company.

Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a company focused on the development of rare cancer therapeutics, today announced that it is changing its name to Cornerstone Pharmaceuticals, Inc.

Rafael Holdings, Inc., a pharmaceutical holding company focused on developing novel cancer metabolism therapeutics through its Barer Institute and investment in Rafael Pharmaceuticals, Inc., announced the appointment of Mary Margaret Huizinga, MD, MPH as Chief Development and Medical Officer, effective October 18, 2021.

Rafael Holdings, Inc., (NYSE: RFL) and Rafael Pharmaceuticals today announced that Ameet Mallik , CEO of Rafael Holdings, Inc., Sanjeev Luther , President & CEO of Rafael Pharmaceuticals, and Tim Pardee , Co-Chief Medical Officer of Rafael Pharmaceuticals, presented at the Raymond James 2021 Human Health Innovation Conference.